Factors associated with the decision to continue adjuvant endocrine therapy for five more years in a diverse sample of breast cancer survivors.
Year: 2023
Type: conference-abstract
Source: JCO Oncology Practice
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: American Cancer Society
OpenAlex ID: W4387962168
